Yucui Jin

847 total citations
30 papers, 551 citations indexed

About

Yucui Jin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yucui Jin has authored 30 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Yucui Jin's work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers) and Bone Metabolism and Diseases (7 papers). Yucui Jin is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers) and Bone Metabolism and Diseases (7 papers). Yucui Jin collaborates with scholars based in China, United States and Denmark. Yucui Jin's co-authors include Changyan Ma, Yuexin Xu, Jia‐Shu Yang, Bing Yao, Lingyun Li, Yunfei Ma, Lingyun Li, Shuang Qu, Jianlei Lü and Yuting Tang and has published in prestigious journals such as FEBS Letters, British Journal of Cancer and Experimental Cell Research.

In The Last Decade

Yucui Jin

30 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yucui Jin China	15	445	267	76	37	32	30	551
Yongzheng Ma China	11	483 1.1×	314 1.2×	71 0.9×	43 1.2×	35 1.1×	18	652
Danfeng Xue China	10	367 0.8×	117 0.4×	117 1.5×	41 1.1×	45 1.4×	15	604
Manoj Nepal South Korea	13	403 0.9×	121 0.5×	114 1.5×	46 1.2×	22 0.7×	25	535
Z. Peter Wang China	14	390 0.9×	128 0.5×	121 1.6×	14 0.4×	31 1.0×	18	524
Zhongqiang Guo China	13	346 0.8×	150 0.6×	90 1.2×	16 0.4×	35 1.1×	24	539
Shun-Fa Yang Taiwan	14	348 0.8×	180 0.7×	112 1.5×	10 0.3×	64 2.0×	21	496
Jinyuan Pan China	10	247 0.6×	144 0.5×	100 1.3×	11 0.3×	38 1.2×	12	421
Kulsoom Zahra India	5	327 0.7×	225 0.8×	53 0.7×	10 0.3×	39 1.2×	7	481
Ziming Wang China	13	272 0.6×	149 0.6×	71 0.9×	10 0.3×	43 1.3×	45	471

Countries citing papers authored by Yucui Jin

Since Specialization

Citations

This map shows the geographic impact of Yucui Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yucui Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yucui Jin more than expected).

Fields of papers citing papers by Yucui Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yucui Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yucui Jin. The network helps show where Yucui Jin may publish in the future.

Co-authorship network of co-authors of Yucui Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Yucui Jin. A scholar is included among the top collaborators of Yucui Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yucui Jin. Yucui Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Ming, Cheng Tang, Shao‐Meng Li, et al.. (2025). NSUN2-mediated m5C modification of KDM6B mRNA enhances osteoclast differentiation and promotes breast cancer bone metastasis. Cancer Letters. 631. 217939–217939. 2 indexed citations

Huang, Jun, Jing Gong, Lishuang Li, et al.. (2025). Colla Corii Asini regulate collagen regeneration in UV exposure-induced skin photoaging in mice. Chinese Medicine. 20(1). 146–146. 1 indexed citations

Huang, Jing, et al.. (2024). A Circadian Rhythm-related Signature to Predict Prognosis, Immune Infiltration, and Drug Response in Breast Cancer. Current Medicinal Chemistry. 32(3). 608–626. 3 indexed citations

Yao, Bing, Xiangwei Zeng, Zhi Wang, et al.. (2024). KMT2D‐mediated H3K4me1 recruits YBX1 to facilitate triple‐negative breast cancer progression through epigenetic activation of c‐Myc. Clinical and Translational Medicine. 14(7). e1753–e1753. 6 indexed citations

Yao, Bing, Shang Li, Jingwan Zhou, et al.. (2023). EBF2 Links KMT2D‐Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN. Advanced Science. 11(2). e2302037–e2302037. 8 indexed citations

Tang, Yuting, Liu Yang, Xiaoshu Zhu, et al.. (2023). ALKBH5-mediated m6A demethylation of HS3ST3B1-IT1 prevents osteoarthritis progression. iScience. 26(10). 107838–107838. 10 indexed citations

Tang, Yuting, Siyang Ding, Jia‐Shu Yang, et al.. (2023). METTL3-mediated m6A modification of IGFBP7-OT promotes osteoarthritis progression by regulating the DNMT1/DNMT3a-IGFBP7 axis. Cell Reports. 42(6). 112589–112589. 18 indexed citations

Chen, Yanlin, Yunfei Ma, Yuting Tang, et al.. (2023). DUSP1 promotes pancreatic cancer cell proliferation and invasion by upregulating nephronectin expression. ONCOLOGIE. 25(6). 681–690. 1 indexed citations

Ding, Siyang, Yunfei Ma, Jia‐Shu Yang, et al.. (2023). MiR-224-5p inhibits osteoblast differentiation and impairs bone formation by targeting Runx2 and Sp7. Cytotechnology. 75(6). 505–516. 7 indexed citations

10.

Zhang, Ming, Jue Wang, Yucui Jin, et al.. (2022). YTHDF2-mediated FGF14-AS2 decay promotes osteolytic metastasis of breast cancer by enhancing RUNX2 mRNA translation. British Journal of Cancer. 127(12). 2141–2153. 26 indexed citations

11.

Yang, Ying, Jiaxue Huang, Yucui Jin, et al.. (2022). TFPI inhibits breast cancer progression by suppressing ERK/p38 MAPK signaling pathway. Genes & Genomics. 44(7). 801–812. 13 indexed citations

12.

Yang, Jia‐Shu, Ming Zhang, Dawei Yang, et al.. (2021). m6A-mediated upregulation of AC008 promotes osteoarthritis progression through the miR-328-3p‒AQP1/ANKH axis. Experimental & Molecular Medicine. 53(11). 1723–1734. 51 indexed citations

13.

Jin, Yucui, Ming Zhang, Rui Duan, et al.. (2020). Long noncoding RNA FGF14-AS2 inhibits breast cancer metastasis by regulating the miR-370-3p/FGF14 axis. Cell Death Discovery. 6(1). 103–103. 25 indexed citations

14.

Yang, Jia‐Shu, Yuting Tang, Ming Zhang, et al.. (2020). Establishment and characterization of an immortalized human chondrocyte cell line. Biotechnology Letters. 42(5). 707–716. 3 indexed citations

15.

Yang, Jia‐Shu, et al.. (2019). αB-crystallin (CRYAB) regulates the proliferation, apoptosis, synthesis and degradation of extracellular matrix of chondrocytes in osteoarthritis. Experimental Cell Research. 382(2). 111459–111459. 10 indexed citations

16.

Xu, Yuexin, Lingyun Li, Yuting Tang, et al.. (2019). Icariin promotes osteogenic differentiation by suppressing Notch signaling. European Journal of Pharmacology. 865. 172794–172794. 36 indexed citations

17.

Lü, Jianlei, Xiang Chen, Shuang Qu, et al.. (2017). Oridonin induces G2/M cell cycle arrest and apoptosis via the PI3K/Akt signaling pathway in hormone-independent prostate cancer cells. Oncology Letters. 13(4). 2838–2846. 44 indexed citations

18.

Chen, Xiang, Rui Duan, Yucui Jin, et al.. (2017). Osterix Decreases the Chemosensitivity of Breast Cancer Cells by Upregulating GALNT14. Cellular Physiology and Biochemistry. 44(3). 998–1010. 5 indexed citations

19.

Xu, Yuexin, Bing Yao, Kaikai Shi, et al.. (2015). Phosphorylation of Serine422 increases the stability and transactivation activities of human Osterix. FEBS Letters. 589(7). 857–864. 10 indexed citations

20.

Jin, Yucui. (2011). 3,3′-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation. Molecular and Cellular Biochemistry. 358(1-2). 345–354. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact